Heidi Brown, MD, of the UW Ob-Gyn Division of Advanced Pelvic Surgery, published a study in the journal Female Pelvic Medicine and Reconstructive Surgery that examined the effectiveness of the Eclipse system on treating fecal incontinence.
“A 12-Month Clinical Durability of Effectiveness and Safety Evaluation of a Vaginal Bowel Control System for the Non-Surgical Treatment of Fecal Incontinence” followed 73 women through a 12-month test of the Eclipse vaginal insert for bowel control.
“The current study shows that after the VBC system is successfully fit it is a highly effective and durable nonsurgical treatment option for FI. This study validates the prior work demonstrating safety and efficacy of the VBC system at 1 month and demonstrates similar effectiveness and safety profile by both subjective and objective measures at 3, 6, and 12 months. In addition, it was found that nearly half (46%) of PP subjects had complete continence, and more than 80% of remaining PP subjects had more than a 75% reduction in FI symptoms at 12 months.”
Following publication of the paper (read the full text here), Brown visited the Centers for Medicare and Medicaid Services (CMS) to advocate for Medicare coverage of the Eclipse device. CMS is currently weighing whether to cover the device – currently, patients covered by Medicare are only offered a more expensive, invasive surgical option to treat fecal incontinence. While CMS debates whether to cover it, some private insurers have decided to offer it, recognizing the significant cost savings compared to surgical options. Medicare coverage is extremely important for the future of the device.
Thank you, Dr. Brown, for representing patients’ best interests!